Abstract
Introduction. The gold standard for surgical treatment of patients with advanced proliferative diabetic retinopathy (PDR) is vitreoretinal surgery (VRS). However, the optimal timing for the removal of early cataracts in this patient category remains an open question. Objective: to evaluate the effectiveness of phacoemulsification of complicated early cataracts as a second stage after VRS in patients with advanced proliferative diabetic retinopathy PDR. Material and methods. The study included 216 patients diagnosed with PDR and complicated early cataracts. These patients were divided into four groups based on the surgical approach. Group I (n = 77): Stage 1 – vitreoretinal surgery (VRS) with silicone tamponade: Stage 2 – phacoemulsification of cataracts (PhEC) with intraocular lens (IOL; implantation performed simultaneously with silicone oil removal. Group II (n = 76): Stage 1 – PhEC with IOL implantation combined with VRS and silicone tamponade; Stage 2 – silicone oil removal from the vitreous cavity. Groups I and II were further divided into two subgroups. Subgroup Ia (n = 62): operations were performed as described above. Tear fluid samples were collected from some patients (n = 17) before surgery and on the second day after Stage 1. Subgroup Ib (n = 15): patients received an intravitreal injection of an angiogenesis inhibitor 10–14 days before VRS in a single dose of 0.5 mg. Subgroup IIa (n = 62): operations were performed as described above. Tear fluid samples were collected from some patients (n = 17) before surgery and on the second day after Stage 1. Subgroup IIb (n = 14): patients received an intravitreal injection of an angiogenesis inhibitor 10–14 days before VRS in a single dose of 0.5 mg. Group III (n = 32): Stage 1 – VRS with gas-air tamponade. Stage 2 – PhEC with IOL implantation. Group IV (n = 31): PhEC was performed simultaneously with VRS using a gas-air mixture for tamponade. Results. Patients in subgroup Ia and Group III showed better visual function outcomes compared to those in subgroup IIa and Group IV, respectively (p < 0.001). The intensity of the inflammatory response (2–3 points) was significantly higher in subgroup IIa (p < 0.001) and Group IV (p < 0.001) compared to subgroup Ia and Group III, respectively. Neovascular glaucoma was significantly more common in subgroup IIa patients (n = 9; 14.5%) compared to subgroup Ia (n = 2; 3.2%, p = 0.027). Similarly, the incidence of neovascular glaucoma was higher in Group IV (n = 6; 19.3%) compared to Group III (n = 1; 3.1%, p = 0.04). Subgroup IIa showed 2–2.5 times higher concentrations of IL-8, MCP-1, and ICAM-1 molecules compared to subgroup Ia. Conclusion. Phacoemulsification of early cataracts as a second stage after VRS in patients with advanced PDR provides a gentle approach to surgical treatment for this category of patients. This approach improves anatomical and functional outcomes and reduces the number and severity of postoperative complications.

This publication has 17 references indexed in Scilit: